News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
A new Philadelphia Business Journal article explains how in addition to being a hub for cell and gene therapy, the Philadelphia area is emerging as an active player in the field of gene editing.
AlphaThera, a startup company co-founded by Andrew Tsourkas, PhD, entered into an expanded license agreement with Penn.
Penn spinout company Verismo Therapeutics has successfully raised $7 million in a pre-Series A round led by BRV Capital Management.
In CBRE’s 2023 Life Sciences Research Talent report, Philadelphia ranked sixth among the top 25 US life sciences markets, two spots above its number eight ranking from last year.
The Penn research team, led by principal investigator Dr. Rajan Jain aims to study how cardiac cells establish and maintain their identity over a lifetime.
The goal of the gift, donated by Wharton alum Marc Wolpow, is to create an incubator and accelerator for student ventures in health care.
In 2022, Startup Genome's Global Startup Ecosystem Report ranked Philadelphia as the 27th-best startup ecosystem in the world and number eleven within the U.S.
This new form of treatment turns off a cancer-attracting function in human blood vessels, which disables the pathways through which the cancer cells travel.
The symposium featured presentations and research posters by CiPD faculty and trainees in the Center’s NIDCR T90/R90 Postdoctoral Training Program as well as invited speakers.
From June 19-20, PCI attended 2023 Tech Connect World Innovation Conference and Expo, an annual event that brings together the creators of breakthrough technologies with corporations.